Pyrimidine compound and medical use thereof
Abstract
The present invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof represented by the following formula [I] wherein each symbol is as defined in the specification and a method of therapeutically or prophylactically treating an undesirable cell proliferation, comprising administering such a compound. The compound of the present invention has superior activity in suppressing undesirable cell proliferation, particularly, an antitumor activity, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, rheumatism, and the like. In addition, the compound of the present invention can be a more effective antitumor agent when used in combination with other antitumor agents such as an alkylating agent or metabolism antagonist.
Claims
exact text as granted — not AI-modified1 .- 24 . (canceled)
25 . A method of preparing a compound of the formula:
comprising
(a) reacting
with cyclopropylamine to form
(b) reacting the product of step (a) with
to form
(c) converting the product of step (b) to
(d) converting the product of step (c) to
(e) reacting the product of step (d) with
to form
(f) reacting the product of step (e) with
to form
and
(g) reacting the product of step (f) with
to form
26 . A compound of the formula:
or a salt or solvate thereof.
27 . A compound of the formula:
or a salt or solvate thereof.
28 . A compound of the formula:
or a salt or solvate thereof.
29 . A compound of the formula:
or a salt or solvate thereof.
30 . A compound of the formula:
or a salt or solvate thereof.
31 . A compound of the formula:
or a salt or solvate thereof.Join the waitlist — get patent alerts
Track US2017029418A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.